Patient-reported outcomes (PROs) can be included in clinical trials as primary or secondary
endpoints and are increasingly recognized by regulators, clinicians, and patients as …

Abstract Background Patient-reported outcomes (PROs) are commonly collected in clinical
trials and should provide impactful evidence on the effect of interventions on patient …

Patient reported outcome measures (PROMs) are key tools when performing clinical
research and PROM data are increasingly used to inform clinical decision‐making, patient …

Objectives Patient-reported outcomes (PROs) provide important information about the
impact of treatment from the patients' perspective. However, missing PRO data may …

Abstract Background Patient-reported outcomes (PROs) are captured within cancer trials to
help future patients and their clinicians make more informed treatment decisions. However …

Head and neck cancers account for approximately 3% of all cancers in the United States
with 62,000 new cases diagnosed annually. The global incidence is approximately 700,000 …

Although patient-reported outcomes (PROs), such as health-related quality of life, are
important endpoints in randomised controlled trials (RCTs), there is little consensus about …

Background Use of patient-reported outcomes (PROs) and patient and public engagement
are critical ingredients of pragmatic trials, which are intended to be patient centered …

Importance Approximately 50% of all patients with cancer have an indication for
radiotherapy, and approximately 50% of radiotherapy is delivered with palliative intent, with …

With the advent of patient-focused drug development, the US Food and Drug Administration
(FDA) has redoubled its efforts to review patient-reported outcome (PRO) data in cancer …